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Recombinant human activated protein C (rhAPC) is one of the treatment panels for
improving vascular dysfunction in septic patients. In a previous study, we reported
that rhAPC treatment in rat endotoxemia improved vascular reactivity, although the
mechanisms involved are still under debate. In the present study, we hypothesized
that rhAPC may improve arterial dysfunction through its nonanticoagulant
properties. Ten hours after injection of LPS in mice (50 mg/kg ip), aortic rings and
mesenteric arteries were isolated and incubated with or without rhAPC for 12 h.
Aortic rings were mounted in a myograph, after which arterial contractility and
endothelium-dependent relaxation were measured in the presence or absence of
nitric oxide synthase or cyclooxygenase inhibitors. Flow (shear stress)-mediated
dilation with or without the above inhibitors was also measured in mesenteric
resistance arteries. Protein expression was assessed by Western blotting.
Lipopolysaccharide (LPS) reduced aortic contractility to KCl and phenylephrine as
well as dilation to acetylcholine. LPS also reduced flow-mediated dilation in
mesenteric arteries. In rhAPC-treated aorta and mesenteric arteries, contractility
and endothelial responsiveness to vasodilator drug and shear stress were improved.
rhAPC treatment also improved LPS-induced endothelial dysfunction; this effect was
associated with an increase in the phosphorylated form of endothelial nitric oxide
synthase and protein kinase B as well as cyclooxygenase vasodilatory pathways, thus
suggesting that these pathways, together with the decrease in nuclear factor-κB
activation and inducible nitric oxide synthase expression in the vascular wall, are
implicated in the endothelial effect of rhAPC. In conclusion, ex vivo application of
rhAPC improves arterial contractility and endothelial dysfunction resulting from
endotoxemia in mice. This finding provides important insights into the mechanism
underlying rhAPC-induced improvements on arterial dysfunction during septic shock.
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